FENOfibrate as an early treatment option in Type 1 Diabetes (FENO-T1D) - A randomized clinical trial assessing the effects of fenofibrate on beta cell function and lipid metabolism in newly diagnosed type 1 diabetes

Pernille Emilie Petersen

FENOfibrate as an early treatment option in Type 1 Diabetes (FENO-T1D) - A randomized clinical trial assessing the effects of fenofibrate on beta cell function and lipid metabolism in newly diagnosed type 1 diabetes

Pernille Emilie Petersen

Steno Diabetes Center Copenhagen

Originalsprog	Engelsk
Kvalifikation	PhD
Bevilgende institution	Københavns Universitet
Vejledere/rådgivere	Pociot, Flemming, Vejleder
Bevillingsdato	20 jun. 2025
Status	Udgivet - 20 jun. 2025

Citationsformater

@misc{ad88e71266914ea8af58b7a4879b2d3e,

title = "FENOfibrate as an early treatment option in Type 1 Diabetes (FENO-T1D) - A randomized clinical trial assessing the effects of fenofibrate on beta cell function and lipid metabolism in newly diagnosed type 1 diabetes",

author = "Petersen, {Pernille Emilie}",

year = "2025",

month = jun,

day = "20",

language = "English",

school = "University of Copenhagen",

}